Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications

Kai Liu; Elisa Lázaro-Ibáñez; Michael Lerche; Daniel Lindén; Anna Salvati; Alan Sabirsh

doi:10.1038/s41467-024-47726-2

Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications

Kai Liu, Elisa Lázaro-Ibáñez, Michael Lerche, Daniel Lindén, Anna Salvati, Alan Sabirsh^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

52 Downloads (Pure)

Original language	English
Article number	3853
Number of pages	4
Journal	Nature Communications
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41467-024-47726-2
Publication status	Published - 9-May-2024

Access to Document

10.1038/s41467-024-47726-2Licence: CC BY

Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applicationsFinal publisher's version, 478 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{b9f0868073af4a25b2ac25917f0b483c,

title = "Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications",

author = "Kai Liu and Elisa L{\'a}zaro-Ib{\'a}{\~n}ez and Michael Lerche and Daniel Lind{\'e}n and Anna Salvati and Alan Sabirsh",

year = "2024",

month = may,

day = "9",

doi = "10.1038/s41467-024-47726-2",

language = "English",

volume = "15",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications

AU - Liu, Kai

AU - Lázaro-Ibáñez, Elisa

AU - Lerche, Michael

AU - Lindén, Daniel

AU - Salvati, Anna

AU - Sabirsh, Alan

PY - 2024/5/9

Y1 - 2024/5/9

UR - http://www.scopus.com/inward/record.url?scp=85192854208&partnerID=8YFLogxK

U2 - 10.1038/s41467-024-47726-2

DO - 10.1038/s41467-024-47726-2

M3 - Letter

C2 - 38724506

AN - SCOPUS:85192854208

SN - 2041-1723

VL - 15

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 3853

ER -

Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applications

Access to Document

Handle.net

Other files and links

Cite this